Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 141-160 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 141 | Muon Space lowweak | Opp 3 Risk 3 | Thesis: Muon Space has some long-horizon optionality because the reviewed sources context places it in satellite constellations and atmospheric/ocean/land measurement, suggesting a real operating footprint in an attractive segment. Why now: The most recent dated context is a May 22, 2026 job posting indicating contracting and legal operations needs, which may imply organizational buildout but is weak evidence for a major catalyst. Evidence
Caveats: The reviewed sources contain no direct positive or negative company-specific events. The May 22, 2026 job posting is operational context, not proof of revenue or contracts. Citation |
| 142 | NordSpace Corp. lowweak | Opp 3 Risk 3 | Thesis: Reviewed evidence context identifies NordSpace as one of three Canadian rocket startups awarded government funding, which is a constructive signal for a long-horizon launch-company buildout, but there is no available in-window evidence to assess amount, timing, milestones, or commercialization follow-through. Why now: The only directional clue is the membership-support article reference: but the reviewed sources includes no, no summary, and no available post-recent evidence window evidence, so timing and durability are uncertain. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article ID: but the reviewed sources provide no or article summary. Opportunity case relies on generic funding support mention without current milestone evidence. |
| 143 | Orbit Fab lowweak | Opp 3 Risk 2 | Thesis: Orbit Fab appears strategically interesting in on-orbit refueling and space logistics. The company website summary describes 'In-Space Fuel Delivery,' RAFTI refueling interfaces, and 'Hydrazine Delivery in GEO for 100kg. Available in 2025,' which would matter over a 1 year+ horizon if still current, but that article is dated December 24, 2022 and outside the 90-day recent evidence window, so it is only weak historical context. Within retained evidence, an undated external list says Orbit Fab is 'operating' in in-orbit servicing, which supports relevance but not a strong near-current thesis. Why now: Why now is only moderate because retained evidence after filtering consists of undated context from Space Index, not a dated current catalyst; the older company-site article from December 24, 2022 may indicate strategic readiness, but recency is weak Evidence
Caveats: Retained evidence is weak context and supporting article context, not direct event/fact evidence. The more detailed article is dated December 24, 2022 and was dropped by the 90-day recent evidence window; it should not be treated as current proof. The undated Space Index row is relevance context only and not recency proof. |
| 144 | OrbitAID Aerospace lowweak | Opp 3 Risk 2 | Thesis: OrbitAID appears positioned in on-orbit refueling, docking, repair, inspection, and life-extension services, which could be strategically attractive over a 1 year+ horizon if execution follows, but the reviewed sources only provides undated article-level company context rather than dated wins, funding, customers, or milestones. Why now: Why now is weak because the surviving evidence is undated company-context material rather than a fresh milestone. Recency-sensitive claims are uncertain Evidence
Caveats: Evidence kept after recent evidence window is undated and marked context, not recency proof. No direct positive event, contract, financing, or customer traction is available. Same-article repeated rows are not independent confirmation. |
| 145 | Orbital lowweak | Opp 3 Risk 2 | Thesis: Among this screen, Orbital has one of the clearer positive reviewed sources rationales: it is described as a private space startup with funding and a planned LEO satellite for orbital data centers, which suggests longer-horizon strategic buildout potential if execution continues, and, no provided in reviewed sources). Why now: The only reason to rank it slightly above peers is the reviewed sources' description of funding plus a planned LEO satellite, which is at least directionally aligned with a 1 year+ horizon. But there is no retained dated evidence to verify recency, sequencing, or milestone timing. Caveats: No are provided for the cited support articles in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. The positive view comes from phase2 rationale text rather than available direct event/facts. |
| 146 | Orbital Recovery Crew lowweak | Opp 3 Risk 3 | Thesis: Orbital Recovery Crew presents a speculative long-horizon opportunity because recent website-level context claims it provides end-to-end retrieval, repositioning, and deorbit services across LEO, MEO, and GEO and is 'Licensed. Insured. Operational since 2011,' which, if accurate, implies operational positioning in on-orbit servicing and debris removal. Why now: The only retained evidence is a page with May 21, 2026, within the 90-day window, indicating recent discoverable claims of operations and service scope, but not a third-party validated catalyst. Evidence
Caveats: Evidence is company-site article context, not independent confirmation. No direct positive or negative dated events are available. Same-article repeated rows are not independent confirmation. |
| 147 | Planet Labs PBC lowweak | Opp 3 Risk 3 | Thesis: Planet Labs is clearly relevant as a satellite constellation and geospatial data company, but the reviewed sources only provides generic article-level business description rather than a dated catalyst or company-specific contract milestone. Why now: Why-now is weak: the only in-window evidence is an April 5, 2026 startup-listing article describing Planet as operating its own satellite constellation and geospatial analytics platform, which is durable context but not a clear catalyst. Evidence
Caveats: Evidence is only supporting article context, not direct company event or fact evidence with strong materiality. No direct positive or negative dated events are available. This is a low-conviction watchlist name in these reviewed sources. |
| 148 | Reaction Dynamics lowweak | Opp 3 Risk 3 | Thesis: Reviewed evidence rationale identifies Reaction Dynamics as one of three Canadian rocket startups awarded government funding. Government support can be a meaningful de-risking signal for a 1 year+ development runway if still current. Why now: The support is tied to article: in the membership rationale, which suggests a relatively recent funding-related development, but the active evidence set still contains zero available rows after recent evidence filtering. Caveats: Government funding mention is promising but unquantified in the active evidence set. No chronology-confirmed operational updates are available. |
| 149 | Sierra Nevada Corporation lowweak | Opp 3 Risk 3 | Thesis: Among this screen, Sierra Nevada Corporation has one of the more plausible long-horizon opportunity setups because the reviewed sources rationale says SNC has a small satellite constellation, Vindler 2.0, and on-orbit RF data transmission activity, which could indicate real space-communications or constellation relevance if validated. Why now: If the referenced constellation and on-orbit transmission activity are current, they could matter over a 1 year+ horizon; however, the reviewed sources provide no available after-recent evidence window evidence to confirm recency or milestone sequence. Caveats: Phase-2 rationale references: and: but no or article summaries are included. The reviewed sources explicitly warns that the evidence mixes SNC and Sierra Space-adjacent themes. Coverage debug shows zero evidence after recent evidence window, so direct validation is unavailable. |
| 150 | SKY Perfect JSAT lowweak | Opp 3 Risk 2 | Thesis: An undated supporting article context item says Astroscale and SKY Perfect JSAT formed a strategic partnership on on-orbit servicing and that the partnership includes an investment by SKY Perfect JSAT, which could support strategic optionality in adjacent space services if current Why now: This is one of the only companies in the screen with any current evidence surviving the recent evidence window, but it is undated supporting context, so why-now confidence is still limited Evidence
Caveats: Evidence is undated and supporting article context only. Same article appears in multiple weak-context rows and is not independent confirmation. No direct positive event/fact beyond supporting context. |
| 151 | Spacecoin lowweak | Opp 3 Risk 3 | Thesis: Spacecoin may have speculative upside over a 1 year+ horizon because the reviewed sources describes it as a private blockchain startup using satellite-based transactions and aiming at a decentralized satellite network, which could represent an emerging infrastructure concept if execution materializes. Why now: If the network concept is advancing, that could be relevant over a long horizon, but the reviewed sources offers no available recency-validated milestone evidence after recent evidence window. Caveats: Phase-2 rationale references and, but no or summaries are included. Business-model adjacency to satellite communications is not the same as proven operating traction. Coverage debug shows zero evidence after recent evidence window. |
| 152 | Spaceflux lowweak | Opp 3 Risk 1 | Thesis: Spaceflux has a plausible long-horizon opportunity setup because the reviewed sources' membership rationale says it received a £100K follow-on investment through a UK space funding program and notes relevance to debris tracking. That can support an SDA-adjacent thesis, but the reviewed sources lack direct positive evidence and gives no or dated article detail to confirm magnitude or timing (: not provided in reviewed sources). Why now: A follow-on investment could matter over 1 year+ if it extends development in debris tracking, but there is no available dated evidence within the recent evidence window and no direct article summary/ in the reviewed sources. Caveats: Only article-level rationale is available. Funding size may be modest, but reviewed sources does not provide enough context to judge materiality precisely. No representative article or quote available. |
| 153 | SWISSto12 lowweak | Opp 3 Risk 2 | Thesis: The reviewed sources membership rationale describes SWISSto12 as delivering HummingSat GEO telecom platforms and NEASTAR-1 direct-to-device media broadcasting capability, which, if current, suggests exposure to durable satellite communications platform programs over a 1 year+ horizon. Why now: There is no dated evidence retained after recent evidence window for SWISSto12. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so the timing case is not established from these reviewed sources. Caveats: Assessment relies only on the reviewed sources' membership rationale, not direct quoted event/fact evidence with support. No representative articles are included despite article IDs being referenced in the rationale. Potential opportunity could be meaningful, but evidentiary support inside these reviewed sources is too thin for a stronger score. |
| 154 | TM2SPACE Technologies lowweak | Opp 3 Risk 4 | Thesis: TM2SPACE may have opportunity from reported selection for IN-SPACe funding under the Technology Adoption Fund for AI-powered star tracker systems, but the reviewed sources does not include the underlying article summaries or evidence in the served evidence section. Why now: The membership rationale references selection for IN-SPACe funding and AI-powered star tracker work using article IDs, and: but no article summaries, or direct evidence are available in these reviewed sources after recent evidence window, so recency and materiality cannot be independently verified from the evidence body. Caveats: No representative articles, or available evidence available to cite directly beyond membership rationale. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window. Scoring is conservative because reviewed sources support is incomplete in the visible evidence section. |
| 155 | True Anomaly Centennial lowweak | Opp 3 Risk 2 | Thesis: Reviewed evidence membership rationale says True Anomaly was included among 14 vendors selected by the U.S. Space Force for space monitoring satellites under the Andromeda program. If current, that implies meaningful government-program relevance over a 1-year-plus horizon, but the reviewed sources lack citeable direct evidence or. Why now: Government program selection could matter over 1 year+, but the reviewed sources does not provide surviving evidence with timing details after recent evidence window. Caveats: No -bearing direct evidence row is available for the referenced Andromeda selection article. Selection does not prove revenue realization or contract scale. |
| 156 | Turion Space lowweak | Opp 3 Risk 3 | Thesis: Turion Space may have an attractive defense and space-monitoring positioning based on the membership rationale mentioning fundraising, U.S. government contracts, STRATFI launches, and Andromeda selection, but the reviewed sources includes no within the recent evidence window evidence or article summaries to support a high-conviction opportunity ranking. Why now: No within the recent evidence window evidence was available in these reviewed sources, so the timing case is weak despite the strategic framing in the membership rationale. Caveats: Membership rationale references article IDs and, but no article content is provided here for citation. Evidence recent evidence review shows 0 kept rows. Scores remain conservative because the reviewed sources lack usable direct evidence. |
| 157 | Vast, Inc. lowweak | Opp 3 Risk 3 | Thesis: Reviewed evidence rationale says Vast raised $500M and is building Haven commercial space stations and related habitats, which would be material long-duration opportunity if current, but these reviewed sources contain no within the recent evidence window direct evidence or representative article summaries to support a stronger score. Why now: Why-now is unproven from these reviewed sources because no dated evidence survived the 90-day recent evidence window despite 11 articles considered. Caveats: Phase2 membership rationale references and, but no summaries or evidence are available for citation. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Scores remain near low baseline due to absence of directly citable local evidence. |
| 158 | Voyager Technologies, Inc. lowweak | Opp 3 Risk 3 | Thesis: Reviewed evidence context says Voyager Technologies is developing the Starlab space station, which is strategically meaningful for a 1 year+ horizon if execution continues, but no direct in-window evidence is available to confirm current milestones, financing, contract conversion, or timetable. Why now: No current catalyst is evidenced in the reviewed sources. Although membership support references article IDs and, the reviewed sources show 0 article IDs after recent evidence window and 0 evidence after recent evidence window, so business-state recency cannot be established. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article IDs and, but the reviewed sources provide no or article summaries for citation. |
| 159 | WISeKey International Holding AG lowweak | Opp 3 Risk 4 | Thesis: Reviewed evidence context indicates WISeKey, via WISeSat, is tied to a planned QSOC 100-satellite constellation with post-quantum satellite launches. If executed, that could matter over a 1 year+ horizon, but the reviewed sources provide no current in-window evidence confirming launch cadence, financing, customer uptake, or operational progress. Why now: There is no documented near-term catalyst in the available evidence. Membership support cites article IDs and, but the reviewed sources reports 0 article IDs after recent evidence window and 0 evidence after recent evidence window. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article IDs and, but the reviewed sources does not include or article summaries for citation. Risk is inferred from lack of current execution proof, not from a confirmed adverse event. |
| 160 | Xona Space lowweak | Opp 3 Risk 2 | Thesis: Xona has potential strategic opportunity because the reviewed sources describes Pulsar as a low-Earth-orbit positioning, navigation, and timing infrastructure using 258 small satellites, implying an ambitious constellation and differentiated service if executed. Why now: Why now is weak: the only surviving evidence is undated, so recency-sensitive claims are uncertain Evidence
Caveats: Evidence is undated and should not be treated as recency proof. No direct positive event or traction evidence is available. Opportunity case is strategic but low-conviction. |
Risk view
Showing rows 381-400 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 381 | Spaceworks lowweak | Opp 1 Risk 1 | Thesis: No retained adverse evidence is provided, so no evidence-based risk thesis can be made. Why now: No within the recent evidence window retained catalyst is available. The phase-2 rationale references, but no, timestamp, or retained summary is included. Caveats: Support is provisional single-article context only. No retained direct evidence after recent evidence window. Payload mention does not prove company-level commercial traction. |
| 382 | SSC Space lowweak | Opp 1 Risk 1 | Thesis: No material negative thesis is supportable from these reviewed sources because no direct negative evidence remains after recent evidence filtering. Why now: There is no retained within the recent evidence window evidence for a current catalyst. Caveats: Phase-2 rationale mentions a sponsored article and a partnership supporting Firefly's Blue Ghost lunar lander antennas, citing, but no or article summary is provided in these reviewed sources. Coverage debug shows 3 articles considered and 0 after recent evidence window. Sponsored-article context would be weaker than direct event/fact evidence even if fully provided. |
| 383 | ST Engineering lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available in the reviewed sources. Risk is limited to evidentiary uncertainty and boundary ambiguity around whether this specific activity is meaningful to ST Engineering's forward space thesis, not to a negative company event (: not provided in reviewed sources). Why now: There is no usable dated direct evidence inside the recent evidence window; the reviewed sources explicitly shows articles after recent evidence window = 0 and evidence after recent evidence window = 0, so recency-based timing is unsupported. Caveats: No direct evidence remained after the recent evidence filter. Representative articles are empty, so no is available in the reviewed sources. Membership rationale is weaker than company-specific event evidence. |
| 384 | Star Catcher Industries, Inc. lowweak | Opp 1 Risk 1 | Thesis: There is also no direct adverse evidence retained inside the 90-day recent evidence window, so no material risk thesis is supported beyond normal uncertainty from missing current evidence. Why now: Why now is weak because the company had 10 articles considered, but zero article IDs and zero evidence remained after the 90-day recent evidence window cutoff of March 29, 2026; recency-based business-state judgment is therefore unavailable from these reviewed sources. Caveats: No retained evidence after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Phase-2 membership rationale is not directional proof and cites support article IDs without, so it cannot be used as a fully cited factual thesis. |
| 385 | Starfighters Space lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available within the reviewed sources' recent evidence window. Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Starfighters Space. Caveats: Phase-2 membership rationale references multiple article IDs, but the reviewed sources provide no article for citation. |
| 386 | Starfish Space lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources have no retained 90-day adverse evidence, so there is not enough for a risk thesis. Why now: No retained article IDs or evidence remain after recent evidence filtering, so there is no current evidence-based catalyst in the reviewed sources. Caveats: Single-article historical context is not retained within the recent evidence window. Absence of negative evidence is not positive evidence. Scoring is conservative because the current reviewed sources is effectively ungrounded for direction. |
| 387 | Starlab lowweak | Opp 1 Risk 1 | Thesis: No material risk thesis is supportable because the reviewed sources retains no direct negative evidence within the recent evidence window. Why now: Why now is weak: the reviewed sources indicates zero evidence after recent evidence window, so there is no retained current catalyst or current operating-state evidence for Starlab. Caveats: Coverage after recent evidence window is empty for this company. Phase-2 membership rationale references, but no article summary or quoted evidence is included in the retained reviewed sources, so it cannot be used for factual claims here. |
| 388 | StatSat lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources does not retain sufficient company-specific adverse evidence to support a risk thesis. Why now: The membership rationale references article and says AISSat-4 is operated by StatSat, but no retained evidence or are present after recent evidence window, leaving recency and business impact uncertain. Caveats: The only described support is a limited operational reference, not a clear catalyst. No direct dated evidence row is retained in the reviewed sources. |
| 389 | Swedish Space Corporation lowweak | Opp 1 Risk 1 | Thesis: No material adverse company-specific evidence is available in the retained recent evidence window. Risk score is kept slightly above zero only because coverage is thin and business status is unconfirmed in the reviewed sources. Why now: There is no current catalyst supported by retained evidence. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so recency and business-state changes cannot be assessed from these reviewed sources. Caveats: No current evidence is provided for the cited support article in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Phase2 rationale is weaker than direct company-specific event evidence and should not be treated as strong proof. |
| 390 | SWISSto12 lowweak | Opp 0 Risk 1 | Thesis: No material adverse evidence is shown. The low risk score reflects lack of documented negatives rather than evidence of resilience. Why now: There is no identifiable catalyst because the reviewed sources provide only a passing mention and no direct event or fact evidence. Caveats: No current evidence is provided for. Support level is provisional single-article context only. No evidence available after recent evidence window. |
| 391 | Swoop Technologies lowweak | Opp 1 Risk 1 | Thesis: No direct negative evidence is present. The main risk is that the company may be only tangentially relevant to the targeted space themes, making the opportunity thesis weak rather than making the company negatively exposed (: not provided in reviewed sources). Why now: No inside-recent evidence window evidence are available, and the reviewed sources reports articles after recent evidence window = 0 and evidence after recent evidence window = 0, so there is no supported near-term or long-horizon timing catalyst beyond generic context. Caveats: Single-article company universe but no representative article content or provided. Contract-award framing comes only through membership rationale, not direct evidence. No materiality, scale, or timing detail is available. |
| 392 | TelePIX lowweak | Opp 1 Risk 1 | Thesis: No direct negative evidence is available in the reviewed sources, but absence of current retained evidence means business execution, financing, and mission timing remain uncertain. Why now: Why now is weak because coverage data shows zero articles after recent evidence window and zero evidence after recent evidence window, so there is no current retained catalyst evidence in the last 90 days despite membership support referencing article Caveats: Support exists only in the membership rationale, which cites article: but no or article summary is provided in the reviewed sources, so it cannot be cited as a factual claim under the the evidence standard. Evidence recent evidence review shows kept_rows 0 and coverage data shows evidence after recent evidence window 0. |
| 393 | Telesat Corp lowweak | Opp 1 Risk 1 | Thesis: No retained within the recent evidence window direct negative evidence is available in the reviewed sources, so there is not enough support for a material risk thesis. Why now: Coverage data reports zero article IDs after recent evidence window and zero evidence after recent evidence window, preventing a recency-based ranking call. Caveats: Membership rationale references satellite communications and Lightspeed progress, but no article or retained evidence are supplied for ranking use. Public company status does not itself create a thesis without evidence. |
| 394 | TESAT lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is present. The main limitation is evidentiary: TESAT's relevance may be real, but the reviewed sources does not provide company-specific directional evidence for either upside or downside (: not provided in reviewed sources). Why now: No inside-recent evidence window direct evidence are available, so there is no supported timing argument. Caveats: Relation evidence is context-only and cannot be propagated as direct contract evidence. No or representative article summary is provided. No company-specific materiality data is available. |
| 395 | TESAT Spacecom lowweak | Opp 1 Risk 1 | Thesis: No material negative evidence is provided; risk remains low because the reviewed sources contain only context-level mention. Why now: There is no within the recent evidence window direct company evidence. Membership rationale references, but no is provided and the support level is only provisional single-article context. Caveats: Support is explicitly supporting article context, not direct company-specific event evidence. No retained evidence after recent evidence window. Relations/context-only mentions cannot be used as counterparty propagation evidence. |
| 396 | Thales lowweak | Opp 1 Risk 1 | Thesis: No material adverse thesis is supported by the reviewed sources. The more relevant issue is uncertainty over evidence attribution from Thales Alenia Space to Thales parent. Why now: There is no citable in-recent evidence window article summary or evidence row for Thales in these reviewed sources, and coverage data shows zero article ids after recent evidence window and zero evidence after recent evidence window. Caveats: Phase2 rationale references article ids: and: but no or summaries for them are included here. Parent/subsidiary propagation is explicitly uncertain in the reviewed sources rationale. No direct evidence were available after recent evidence window. |
| 397 | The ePlane Company lowweak | Opp 2 Risk 1 | Thesis: No material adverse evidence is available. The main downside is uncertainty about business fit, commercialization path, and whether the government-support reference is meaningful at the company level. Why now: The government RDI disbursal reference could matter on a 1 year+ horizon, but the reviewed sources lack timestamps, and direct evidence, limiting confidence in timing and materiality. Caveats: No current evidence is provided for Government support mention is contextual and not enough alone to prove commercial traction. Zero evidence available after recent evidence window. |
| 398 | Trishul Space lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available within the recent evidence window. Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Trishul Space. Caveats: Phase-2 membership rationale references article: but the reviewed sources provide no for citation. Accelerator participation context is weaker than direct commercial, funding, or technical milestone evidence. |
| 399 | True Anomaly lowweak | Opp 2 Risk 1 | Thesis: No material adverse evidence is available. Risk remains low-scored due to lack of evidence rather than demonstrated business stability. Why now: Why-now is weak because the cited raise and mission activity appear only in membership rationale, without scoreable dated article details in the current evidence set. Caveats: Membership rationale cites, and, but the supporting articles are not available for direct use. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. A positive thesis requires positive evidence; membership rationale alone only supports a modest watchlist bias. |
| 400 | True Anomaly Centennial lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available in the reviewed sources. Risk remains low-scored only because evidence is absent, not because the business is proven safe. Why now: Why-now visibility is weak because the reviewed sources show zero evidence kept after recent evidence window for this company, so any claimed contract relevance lacks scoreable supporting detail in the current batch. Caveats: Reviewed evidence cites: in membership rationale but does not provide article summary or available evidence, so it cannot be used as direct scoring evidence. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Absence of negative evidence is not positive evidence. |